BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 100 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,078,405 | -48.8% | 375,751 | -9.9% | 0.00% | 0.0% |
| Q2 2023 | $2,106,249 | +143377.5% | 417,079 | -46.3% | 0.00% | 0.0% |
| Q1 2023 | $1,468 | +55.5% | 776,594 | +48.0% | 0.00% | 0.0% |
| Q4 2022 | $944 | -99.8% | 524,557 | +51.2% | 0.00% | – |
| Q3 2022 | $586,000 | -3.8% | 346,980 | +40.2% | 0.00% | – |
| Q2 2022 | $609,000 | -58.0% | 247,540 | -9.0% | 0.00% | -100.0% |
| Q4 2021 | $1,450,000 | -30.2% | 272,035 | +10.8% | 0.00% | 0.0% |
| Q3 2021 | $2,077,000 | -48.1% | 245,517 | -25.2% | 0.00% | -50.0% |
| Q2 2021 | $4,000,000 | +17.2% | 328,158 | +133.3% | 0.00% | 0.0% |
| Q1 2021 | $3,412,000 | -38.6% | 140,630 | -18.9% | 0.00% | -50.0% |
| Q4 2020 | $5,555,000 | +378.1% | 173,330 | +350.9% | 0.00% | +300.0% |
| Q3 2020 | $1,162,000 | +96.9% | 38,444 | +174.9% | 0.00% | 0.0% |
| Q2 2020 | $590,000 | +154.3% | 13,986 | +50.5% | 0.00% | 0.0% |
| Q1 2020 | $232,000 | – | 9,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
| Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
| RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
| Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
| Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
| Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
| Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
| Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
| HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |